SAVI, Mario
 Distribuzione geografica
Continente #
NA - Nord America 3.079
EU - Europa 2.157
AS - Asia 1.459
AF - Africa 16
OC - Oceania 2
SA - Sud America 1
Totale 6.714
Nazione #
US - Stati Uniti d'America 3.013
CN - Cina 941
IE - Irlanda 460
UA - Ucraina 415
SG - Singapore 390
FI - Finlandia 382
SE - Svezia 360
DE - Germania 241
IT - Italia 197
TR - Turchia 99
CA - Canada 65
GB - Regno Unito 43
BE - Belgio 21
NL - Olanda 15
IN - India 14
CI - Costa d'Avorio 12
KR - Corea 7
AT - Austria 4
EG - Egitto 4
LT - Lituania 4
CZ - Repubblica Ceca 3
FR - Francia 3
IR - Iran 3
CH - Svizzera 2
RO - Romania 2
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
CO - Colombia 1
DO - Repubblica Dominicana 1
ES - Italia 1
HK - Hong Kong 1
HR - Croazia 1
IQ - Iraq 1
JP - Giappone 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PL - Polonia 1
Totale 6.714
Città #
Jacksonville 539
Dublin 459
Santa Clara 413
Chandler 361
Singapore 334
Dearborn 264
Beijing 237
Boardman 150
Ashburn 148
Nanjing 136
Princeton 109
San Mateo 100
Izmir 97
Ann Arbor 72
Toronto 64
Helsinki 54
Shenyang 53
Wilmington 50
Nanchang 49
New York 42
Kunming 41
Hefei 40
Hebei 38
Los Angeles 35
Jinan 33
Des Moines 27
Jiaxing 26
Shanghai 23
Changsha 20
Tianjin 18
Brussels 16
Haikou 13
Rome 13
Abidjan 12
Norwalk 12
Guangzhou 11
Woodbridge 11
Ningbo 10
Seattle 10
Fremont 9
Fuzhou 9
Monmouth Junction 9
Florence 8
Taizhou 8
Zhengzhou 8
Milan 7
Naples 7
Rockville 7
Augusta 6
Chengdu 6
Leawood 6
Taiyuan 6
Wuhan 6
Chongqing 5
Hangzhou 5
Seongnam 5
Waanrode 5
Baotou 4
Borås 4
Faenza 4
Falkenstein 4
Houston 4
Vienna 4
Auburn Hills 3
Aversa 3
Birmingham 3
Bremen 3
Brno 3
Dallas 3
London 3
Mumbai 3
Palermo 3
Parma 3
Rio Saliceto 3
Shaoxing 3
Tappahannock 3
Trieste 3
Ardabil 2
Bacoli 2
Bologna 2
Bonate Sotto 2
Cairo 2
Düsseldorf 2
Ferrara 2
Focsani 2
Grafing 2
Kocaeli 2
Lugano 2
Manfredonia 2
Mestre 2
Munich 2
Nanning 2
Napoli 2
Pavia 2
Perugia 2
Ponte A Moriano 2
Seoul 2
Trento 2
Wenzhou 2
Xian 2
Totale 4.374
Nome #
Oligonucleotide Ligation Assay (OLA) e mutazioni silenti del gene CFTR: una rara causa di parziale fallimento del test 144
TRAPIANTO COMBINATO FEGATO-RENE CON CROSS-MATCH POSITIVO:CONTROINDICAZIONE O OPPORTUNITÀ? 97
Alterations of type IV collagen alpha chains in patients with chronic acquired glomerulopathies: analogies with Alport’s syndrome 92
Alterations of type IV collagen alpha chains in patients with chronic acquired glomerulopathies: mRNA levels, protein expression and urinary loss 92
BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study. 89
Fluorescent in situ hybridisation on tissue sections: a quantitative approach with confocal laser scanning microscopy 88
Ruolo dei geni del collagene di tipo IV e dei loro prodotti proteici nelle glomerulopatie umane acquisite 86
BRCA-1 status, molecular markers and clinical viariables in breast cancer (BC) patients with high probability of having an inherited cancer predisposing genetic mutation 84
Valutazione del gene COL4A5 e del suo prodotto proteico nelle nefropatie glomerulari acquisite 84
Insulin dependent diabetes mellitus (IDDM): 12th International Histocompatibility Workshop study 83
BRCA1 and BRCA2 status in a sample of italian women with early onset breast cancer (EOBC) 83
Correlazione fra HLA-DRB1*03 e periaortite cronica: una ipotesi di origine autoimmune 81
BRCA1 and BRCA2 status in a sample of italian women with early onset breast cancer (EOBC) 77
Tipizzazione dei polimorfismi dei geni del locus HLA, delle citochine e dei loro recettori nella Fibrosi Retroperitoneale Idiopatica (FRI) 77
Chronic periaortitis and HLA–DRB1*03: Another clue to an autoimmune origin 77
Molecular profile and clinical variables in BRCA1-positive breast cancers. A population-based study 75
A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes 75
CDC – XM NEGATIVO E RIGETTO IPERACUTO 74
Appearance and evolution of anti-Da (B cell-specific) antibodies after planned immunizations. 73
Clinical heterogeneity of hereditary coproporphyria: diagnostic usefulness of biochemical studies. Study of a familial case 73
Immunological abnormalities in a family with progressive external ophtalmoplegia 73
Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin 72
Riconoscimento in situ di RNA messaggeri umani specifici mediante microscopia confocale in fluorescenza 72
Alport syndrome in Italy. A multicenter screening for COL4A5 gene mutations 72
Febbre Mediterranea Familiare e Sindrome Associata a mutazioni nel recettore TNF-alfa: nuove varianti ed interazioni fra i due geni 71
Clinical, histopathological and biochemical findings in Fabry's disease. A case report 71
CORRELAZIONE FRA HLA-DRB1*03 E PERIAORTITE CRONICA: UNA IPOTESI DI ORIGINE AUTOIMMUNE 70
Human T-cell receptor alpha chain gene during ontogeny 70
T-cell receptor beta-chain gene rearrangement and expression during human thymic ontogenesis. 70
Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population 70
BRCA1 status. Molecular markers and clinical variables in breast cancer (BC) patients with high probability of having an inherited, cancer-predisposing genetic mutation 70
X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene. 70
Malattia di Fabry e linfedema familiare. Descrizione di due casi 69
DUPLICAZIONE DELL DELL’ESONE 13 DEL GENE F8 NEI P ’ESONE PAZIENTI EMOFILICI CON AZIENTI FENO FENOTIPO LIEVE: TIPO LA CASISTICA DELLA REGIONE EMILIA ROMA ROMAGNA GNA 69
Ruolo dei geni del collageno di tipo 4 nelle glomerulopatie acquisite 68
La tecnica multiplex ligation probe amplification (MLPA) per la determinazione dello stato di portatrice in emofilia. 67
Mesangio-proliferative glomerulonephritis with prevalent deposits of IgA and histocompatibility antigens 67
X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene. 67
Febbre Mediterranea Familiare (FMF) e sindrome associata a mutazioni del recettore del TNF-alfa (TRAPS): nuove varianti e cross-talk fra i 2 geni. 67
Fabry's Disease with Familial Lymphedema of the Lower Limbs. Case Report and Family Study 67
Genetica della Febbre Mediterranea Familiare in Italia 66
CORRELAZIONE FRA HLA-DRB1*03 E PERIAORTITE CRONICA: UNA IPOTESI DI ORIGINE AUTOIMMUNE 66
Role of the 4A5 collagen gene and its product in human acquired glomerulopathies 66
Ulteriori nuove mutazioni sul gene COL4A5 mediante PCR e sequenziamento diretto 66
Lymphocyte antibody lymphocytolytic interaction (LALI) with special enphasis on HLA 65
HLA-DRB1 e TNF, ma non CFTR, sono fattori di rischio per la colangite sclerosante 65
HLA ANTIGENS AND INSULIN DEPENDENT DIABETES MELLITUS. A FAMILY STUDY 64
Male breast cancer (MBC) in Parma province: descriptive epidemiology, molecular markers and clinical variables. 63
Expression of TCR beta chain gene N-diversity is not an early event in human thymic ontogeny 63
Rapid and sensitive MLPA approach for identification of deletion carriers in haemophilia 63
HLA-DR antigens and cardiolipin antibodies in northen Italian systemic erythematosus patients. 62
Screeniong for B cell specific antisera. Results from region Italy 1 62
RECIPROCHE IMPLICAZIONI DEL TRAPIANTO DI TESSUTI E DI ORGANI SOLIDI 62
Toxicity due to remission inducing drugs in rheumatoid arthritis. Association with HLA-B35 and Cw4 antigens. 61
Production of anti HLA antisera by planned immunisations 61
Different expression of BRCA1 status and clinical variables in a sample of Italian women with early onset breast cancer (EOBC) 61
Association between DR antigens, rheumatoid arthritis with and without features and systemic lupus erythematousus in northern Italy. 60
Patient waiting for kidney transplantation with antibodiea vs previous bone allograft. A case report 60
Anti HLA antibody evolution in recipients of planned transfusions 60
L'ANALISI MUTAZIONALE DEL GENE COL4A5 MEDIANTE SEQUENZIAMENTO DIRETTO RENDE POSSIBILE LA DIAGNOSI NELLA QUASI TOTALITA'DEI CASI 60
Sospetta eterogeneità genetica nella Febbre Mediterranea Familiare 59
Missense mutations in the COL4A5 gene in patients with X-linked Alport syndrome 59
HLA antigens and IgA mesangial glomerulonephritis 59
Mutation scanning of the entire COL4A5 coding sequence in Alport syndrome and genotype-phenotype correlation 58
Spectrum of F8 gene mutations in haemophilia A patients from a region of Italy: identification of 23 new mutations. 57
Terminal deoxynucleotidyl transferase (TDT) expression correlates with the presence of N regions during human thymic ontogeny 56
HLA-DR antigens and anticardiolipin antibodies in northern Italian systemic lupus erythematosus patients. 56
T-cell receptor beta chain gene rearrangement and expression during human thymic ontogenesis. 56
Medicina genomica. Prospettive e limiti 55
The presence of posttransplant HLA-specific IgG antibodies detected by immunosorbent assay correlates with specific rejection pathologies. 55
What strategy for improving HLA alloimmunization screening in cadaver kidney transplant waiting list? A regional experience (Emilia Romagna-Italy). 55
HLA and type 1 diabetes: a prospective study of all new cases diagnosed in Piedmont one year 55
Screening del gene COL4A5 mediante sequenziamento diretto in pazienti affetti da Sindrome di Alport 55
Missense mutations in the COL4A5 gene in patients with X-linked Alport Syndrome. 54
REPORT OF THE ITALIAN MULTICENTER STUDY ON ALPORT SYNDROME 54
The role of HLA polymorphism in susceptibility to Churg-Strauss syndrome and their influence on disease phenotype 54
HLA-DR frequecies in northen Italy 53
Ruolo dei polimorfismi dei geni dei fattori della coagulazione nella glomerulosclerosi focale e segmentaria idiopatica 52
Hypergammaglobulinemic purpura of Waldenström. (A report of serologic and immunogenetic studies and long-term follow-up in 18 patients). 52
Major COL4A5 gene rearrangements in patients with juvenile type Alport syndrome. 52
Patient waiting for kidney transplantation with antibodiea vs previous bone allograft. A case report 51
TCR beta chian gene ontogeny in human thymus 51
Serologic and genetic aspects of HLA DR antigen study 51
Spettro di mutazioni nel gene F8 in pazienti affetti da Emofilia A della Regione Emilia Romagna. 50
Patient waiting for kidney transplantation with antibodies vs previous bone allograft. A case report 49
Preliminary results of donor specific antibody (DSA) determination by Luminex vs CDC-XM in living and cadaveric kidney transplantation: a regional experience 49
POlimorfisni dei geni delle citochine e dei loro recettori nella Sindrome di Churg-Strauss 48
Similarity of the genetic background in rheumatic diseases between northen patients. 48
Il paziente con anticorpi anti HLA 48
IS HIGH RESOLUTION TYPING IN KIDNEYTRANSPLANTATION WORTHWHILE? A CASE REPORT INTHE LUMINEX ERA 48
Major COL4A5 gene rearrangements in patients with juvenile type Alport syndrome. 47
Studio in CDC dei sieri dei pazienti in lista di attesa per trapianto renale. E' ancora attuale nell'epoca della citofluorimetria? 47
PRELIMINARY RESULTS OF DONOR SPECIFIC ANTIBODY(DSA) DETERMINATION BY LUMINEX VS CDC-XM INLIVING AND CADAVERIC KIDNEY TRANSPLANTATION: AREGIONAL EXPERIENCE 47
Mutation scanning of the entire COL4A5 coding sequence in Alport syndrome and genotype-phenotype correlation. 46
POSITIVE CROSS-MATCH (XM) BEFORE A COMBINED KIDNEY-LIVER TRANSPLANTATION. A CASE REPORT 46
Some immunological reactions during chronic treatment with antiepilectic drugs 45
TCR-beta chain gene rearrangement and expression in human T-cell development and leukemia. 43
Febbre Mediterranea Familiare : necessità di accesso al test genetico sulla base del parere di un clinico esperto. 43
Secondary and Primary Vasculitis Study Group.HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome: 43
Trapianto renale 2006: strategie immunogenetiche 42
Totale 6.400
Categoria #
all - tutte 23.116
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.116


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020809 0 0 0 0 0 180 209 25 120 115 43 117
2020/2021757 9 113 64 5 113 3 73 5 208 6 156 2
2021/2022472 3 3 9 16 12 4 73 98 22 29 46 157
2022/20231.547 199 145 103 102 117 177 10 80 555 2 48 9
2023/2024478 19 70 15 7 44 140 14 30 7 19 45 68
2024/20251.054 109 120 129 75 268 353 0 0 0 0 0 0
Totale 6.720